Michael J Swartz
Overview
Explore the profile of Michael J Swartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
614
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu C, Wolfgang C, Laheru D, Pawlik T, Swartz M, Winter J, et al.
J Gastrointest Surg
. 2012 Feb;
16(4):753-61.
PMID: 22311282
Background: Identifying pancreatic cancer patients at high risk of early mortality following pancreaticoduodenectomy (PD) is important for treatment decisions in a multidisciplinary setting. This study examines the preoperative predictors of...
2.
Swartz M, Petereit D
S D Med
. 2010 Apr;
Spec No:38-40.
PMID: 20401984
Radiation therapy has a pivotal role in the management of lung, breast, prostate, and colorectal cancer. It is frequently used with curative intent as a single treatment modality or, more...
3.
Swartz M, Petereit D
S D Med
. 2010 Apr;
Spec No:60-6.
PMID: 20397493
Radiation therapy has a pivotal role in the management of lung, breast, prostate and colorectal cancer. It is frequently used with curative intent as a single treatment modality or, more...
4.
Hsu C, Herman J, Corsini M, Winter J, Callister M, Haddock M, et al.
Ann Surg Oncol
. 2010 Jan;
17(4):981-90.
PMID: 20087786
Background: Survival for pancreatic ductal adenocarcinoma is low, the role of adjuvant therapy remains controversial, and recent data suggest adjuvant chemoradiation (CRT) may decrease survival compared with surgery alone. Our...
5.
Voong K, Davison J, Pawlik T, Uy M, Hsu C, Winter J, et al.
Hum Pathol
. 2009 Oct;
41(1):113-22.
PMID: 19801164
Pancreatic adenosquamous carcinoma is a rare morphological variant of pancreatic adenocarcinoma with an especially poor prognosis. The purpose of this study is to identify clinicopathologic features associated with prognosis, assess...
6.
Swartz M, Hsu C, Pawlik T, Winter J, Hruban R, Guler M, et al.
Int J Radiat Oncol Biol Phys
. 2009 Aug;
76(3):839-44.
PMID: 19647950
Purpose: Intraductal papillary mucinous neoplasms are mucin-producing cystic neoplasms of the pancreas. One-third are associated with invasive carcinoma. We examined the benefit of adjuvant chemoradiotherapy (CRT) for this cohort. Methods...
7.
Hristov B, Reddy S, Lin S, Cameron J, Pawlik T, Hruban R, et al.
Int J Radiat Oncol Biol Phys
. 2009 Apr;
76(1):176-80.
PMID: 19394156
Purpose: Surgery followed by chemotherapy and radiation (CRT) offers patients with pancreatic adenocarcinoma a chance for extended survival. In some patients, however, resection is difficult because of vascular involvement by...
8.
Herman J, Swartz M, Hsu C, Winter J, Pawlik T, Sugar E, et al.
J Clin Oncol
. 2008 Jul;
26(21):3503-10.
PMID: 18640931
Purpose: To examine the efficacy of adjuvant chemoradiotherapy after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC) in patients undergoing resection at Johns Hopkins Hospital (JHH; Baltimore, MD). Patients And Methods: Between...
9.
Swartz M, Janson K, DeWeese T, Song D
Compr Ther
. 2007 Nov;
33(4):216-22.
PMID: 18025613
Recent technological advances in radiation treatment delivery have allowed relatively higher doses of radiation to be delivered safely to the prostate. Emerging data suggest improvements in disease control with higher...
10.
Swartz M, Hughes M, Frassica D, Herman J, Yeo C, Riall T, et al.
Arch Surg
. 2007 Mar;
142(3):285-8.
PMID: 17372054
Hypothesis: Adjuvant chemoradiation improves local control and survival in patients with node-positive duodenal adenocarcinoma treated with pancreaticoduodenectomy. Design: A retrospective review of outcomes, with a planned comparison with historical controls....